Ecuador Certificado de Libre Venta for Medical Device Registration: Article 25 Content Rules and ARCSA Practice

1. Key takeaways

The Certificado de Libre Venta (CLV) — the free sale certificate — is a mandatory document for the registration of imported products in Ecuador. It must be issued by a competent authority or a highly regulated agency and must state four elements: the trade name, which must match exactly what will appear on the registration certificate; the product code or reference number; the manufacturer together with its address and country; and the manufacturing site together with its address and country. Where an electronic CLV can be verified on the issuing website, ARCSA accepts it and waives legalisation.

The practical estimate used by GRZAN is that the CLV is the single legal document most likely to generate a correction request in an Ecuadorian dossier, because its content is fixed by Article 25 and reviewers compare each stated element against the application form line by line. Companies should therefore treat the CLV not as a routine export formality but as a controlled registration document whose wording, trade name and validity window are planned against the full review timeline.

2. Legal basis

Article 25 fixes the content of the CLV or equivalent document required for imported products. Article 53 creates the reverse channel under which ARCSA itself issues a CLV for devices already holding an Ecuadorian sanitary registration. Article 8 of the general provisions admits the CLV in electronic form, and Article 13 governs when legalisation is required and when the online-verifiability exemption applies. The correction windows of Article 26, items 10–11 — 30 or 60 days depending on the origin of manufacture — define how long the document must remain valid during corrections.

3. Expert insights

Insight one: Article 25 writes trade-name consistency into the law as a mandatory requirement. The provision requires the CLV or equivalent document to state the trade name, which must match what is shown on the registration certificate. This means that the English trade name commonly used by Chinese manufacturers, the export model name and the trade name registered in Ecuador must all be aligned; any divergence between them will surface as a correction request during the completeness review.

Insight two: the issuing body can be a highly regulated agency, not only the competent authority of the country of origin. Article 25 refers to a CLV or equivalent document issued by the competent authority or a highly regulated agency. This opens an alternative route for companies that already hold marketing approvals in Stringently Regulated Authority jurisdictions: a certificate issued in such a market can support the Ecuadorian application even when the country of manufacture has no traditional free sale certificate.

Insight three: Article 25 provides a remedial channel when the CLV content is incomplete. Where the CLV or equivalent document does not meet the content requirements, the applicant must submit sufficient information, supported by a justification from the product manufacturer or endorsed by the competent authority that issued the CLV. This gives Chinese certificates of free sale whose format does not follow the Ecuadorian template a formal basis for rescue instead of automatic rejection.

Insight four: Article 53 builds a reverse issuing channel. ARCSA will issue a CLV for devices that already hold an Ecuadorian sanitary registration, with the application submitted through the automated system designated by ARCSA. This means that once registration in Ecuador is completed, the Ecuadorian CLV can be used to support registrations in other markets — the Ecuadorian certificate carries regional endorsement value.

Insight five: Article 8 of the general provisions makes electronic documents operational. ARCSA accepts the CLV or equivalent document in electronic form provided its authenticity can be verified; in that case no apostille or consular legalisation is required, but the document must still be submitted in PDF with the application. The legalisation exemption is not a submission exemption.

Insight six: Article 25 requires all documents to remain valid for the entire period needed to obtain the registration certificate. A CLV has its own issuance validity, while the Ecuadorian correction windows can run to 30 or 60 days under Article 26 items 10–11. Applying close to the submission date and reserving margin for the correction period is the key to avoiding a CLV that expires mid-review.

4. Practical recommendations

1. Lock the trade name before applying for the CLV: confirm the intended registered trade name with the Ecuadorian licence holder and require the issuing authority to use exactly the same wording on the certificate.
2. Pursue the electronically verifiable version: request an electronic CLV with an online verification code and cite Article 8 of the general provisions to waive legalisation.
3. Use the remedial channel of Article 25 in full: where the certificate format does not comply, prepare in parallel a manufacturer justification letter or an endorsement from the issuing authority.
4. Back-plan the issuance date against the full review cycle plus the correction window: apply neither too early nor only at the moment of submission.
5. After obtaining the certificate, evaluate an Ecuadorian CLV from ARCSA: it can serve as supporting evidence for registrations in other Latin American and Andean markets.

5. Verification checklist

• □ The CLV states the trade name and it matches the intended registered trade name exactly.
• □ The CLV states the product code or reference number.
• □ The CLV states the manufacturer with its address and country.
• □ The CLV states the manufacturing site with its address and country.
• □ The issuing body has been confirmed as a competent authority or a highly regulated agency.
• □ An electronically verifiable version has been obtained, or legalisation has been completed.
• □ The validity of the CLV covers the review cycle and the correction window.

Regulatory information verified as of October 29, 2026

GRZAN supports manufacturers, importers and authorised representatives securing compliant certificates of free sale and equivalent legal documents for medical device registration in Ecuador, from trade-name alignment and Article 25 remedial files to electronic verification and validity planning. For tailored assistance with your Ecuador medical device registration, contact us at info@grzanglobal.com.